The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE crawling higher as Fed and Budget digested

Thu, 19th Mar 2015 11:48

Come midday on Thursday, stocks were registering slight gains as traders digested the policy announcement issued by the US Federal Reserve overnight, but volatility was still evident in other asset classes such as foreign exchange and commodities.At 12.25 the top flight index was 5.8 points higher at 6,951.01, with some effects from Wednesday's Budget from Chancellor George Osborne also still filtering through.As expected, the US central bank yesterday omitted any reference to being "patient" when starting to tighten interest rates, but the 17 members of the Federal Open Market Committee nearly halved their median projection for the level of the Fed funds rate at year-end 2015 to 0.625%.They also lowered their estimates for the following two years despite having reduced their forecasts for inflation and unemployment. The communiqué from the Fed and follow-up conference from Chair Janet Yellen saw the euro/dollar register its large intraday gain since 2000, no less.On Thursday investors were expected to focus on the summit of European Union heads of government and the news-flow surrounding the negotiations with Greece.That came as the yield on 10-year Greek bonds sprinted 62 basis points higher to 11.72%.Against analysts' predictions Norway's central bank maintained its deposit rate at 1.25%, instead of reducing it by 25 basis points. Nonetheless, the monetary authority clearly signalled that it will soon be lowering its key rate further, analysts at Capital Economics said.Earlier in the day Switzerland's central bank, the SNB, kept its target range for the three-month Libor unchanged, at between -1.25% and -0.25%, as expected. However, the SNB cautioned that it could cut rates further or intervene in foreign exchange markets, if necessary, to curb strength in the swiss franc's value.Next drops after full-year profits UK clothing retailerNext grew its underlying pre-tax profit by 12.5% last year as overall sales rose by 7.2%. The company said its share buyback scheme meant that underlying EPS grew by 14.7% and dividends for the full year will increase by 16.3%, to 150p.Auto Trader Group, the UK car classified ad company on Thursday priced 590m shares at 235p/share in its initial public offering in the London market. The company is raising £437m of net proceeds in the offer with its private equity owner, Apax expected to raise around £926.2m out of the flotation. As of 12:18 the shares were changing hands at 268.75p.Chip designer ARM Holdings's market share in servers may reach 20% by 2020, versus less than 1% at present, the company has reportedly said. The London-listed outfit was scheduled to make a presentation at today's Bank of America Merrill Lynch Technology & Beyond Conference, in Taiwan.Electronics components distributor Premier Farnell reported adjusted profits before tax down 3% to reach £74m in 2014 but maintained its full-year dividend pay-out at 10.4p. That came on the back of a 0.8% fall in full-year revenues to £960.1m. However, the company's operating margins declined by less than forecast by analysts, slipping by 40 basis points, to 9.2%. The analyst consensus was for margins of 9%. Earnings per share (EPS) on an adjusted basis came in at 13.8p, down 3.5% from the prior year but ahead of the 13.5p which analysts had pencilled in.AstraZeneca has signed an agreement with Japanese-headquartered company Daiichi Sankyo to jointly commercialise a new drug called Movantik, an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. No longer labelled a controlled substance by the US Drug Enforcement Administration, its launch has been scheduled to take place early in April 2015.Savills reported a 21% increase in pre-tax profit to £84.7m, as revenue rose 19% to £1.08bn driven by a 38% increase in transaction advisory revenue, which the company attributed to the performance of the Savills Studley business in the US, strong performances in Asia and the UK and recovery in some European markets.Market MoverstechMARK 3,247.62 -0.06%FTSE 100 6,952.98 +0.11%FTSE 250 17,422.45 +0.34%FTSE 100 - RisersFresnillo (FRES) 676.00p +4.97%Sports Direct International (SPD) 656.50p +2.58%Antofagasta (ANTO) 698.00p +2.42%BHP Billiton (BLT) 1,492.50p +2.37%Randgold Resources Ltd. (RRS) 4,777.00p +2.18%British Land Co (BLND) 867.00p +2.12%Hammerson (HMSO) 687.00p +2.00%Aviva (AV.) 566.00p +1.89%Aberdeen Asset Management (ADN) 478.30p +1.83%GKN (GKN) 375.30p +1.79%FTSE 100 - FallersNext (NXT) 7,350.00p -3.54%British American Tobacco (BATS) 3,672.50p -3.25%Meggitt (MGGT) 580.00p -1.28%Imperial Tobacco Group (IMT) 3,168.00p -1.03%Mondi (MNDI) 1,349.00p -0.81%Pearson (PSON) 1,490.00p -0.80%Unilever (ULVR) 2,903.00p -0.79%HSBC Holdings (HSBA) 574.80p -0.78%Diageo (DGE) 1,939.00p -0.77%Royal Mail (RMG) 445.40p -0.74%FTSE 250 - RisersPremier Oil (PMO) 146.10p +7.58%Soco International (SIA) 157.80p +6.69%Acacia Mining (ACA) 246.50p +4.94%Supergroup (SGP) 916.00p +4.87%Ophir Energy (OPHR) 130.30p +4.41%Countrywide (CWD) 557.50p +4.30%Crest Nicholson Holdings (CRST) 442.60p +4.09%Vedanta Resources (VED) 457.10p +3.91%Centamin (DI) (CEY) 53.50p +3.68%Hunting (HTG) 482.20p +3.37%FTSE 250 - FallersBrit (BRIT) 278.50p -8.60%Lancashire Holdings Limited (LRE) 634.00p -6.70%Jupiter Fund Management (JUP) 408.90p -4.04%Hiscox Ltd (CDI) (HSX) 816.00p -3.77%Jimmy Choo (CHOO) 168.90p -3.49%Premier Farnell (PFL) 184.90p -3.19%Ladbrokes (LAD) 110.80p -2.38%Ted Baker (TED) 2,751.00p -2.34%Serco Group (SRP) 170.80p -2.18%Hellermanntyton Group (HTY) 346.50p -1.84%
More News
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.